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Abstract
Background: Iodine 125 (
125I) seed irradiation is an effective treatment for unresectable pancreatic cancers.
However, the radiobiological mechanisms underlying brachytherapy remain unclear. Therefore, we investigated the
influence of continuous and low-energy
125I irradiation on apoptosis, expression of DNA methyltransferases
(DNMTs) and cell growth in pancreatic cancers.
Materials and methods: For in vitro
125I seed irradiation, SW-1990 cells were divided into three groups: control
(0 Gy), 2 Gy, and 4 Gy. To create an animal model of pancreatic cancer, the SW 1990 cells were surgically
implanted into the mouse pancreas. At 10 d post-implantation, the 30 mice with pancreatic cancer underwent
125I
seed implantation and were separated into three groups: 0 Gy, 2 Gy, and 4 Gy group. At 48 or 72 h after
irradiation, apoptosis was detected by flow cytometry; changes in DNMTs mRNA and protein expression were
assessed by real-time PCR and western blotting analysis, respectively. At 28 d after
125I seed implantation, in vivo
apoptosis was evaluated with TUNEL staining, while DNMTs protein expression was detected with
immunohistochemical staining. The tumor volume was measured 0 and 28 d after
125I seed implantation.
Results:
125I seed irradiation induced significant apoptosis, especially at 4 Gy. DNMT1 and DNMT3b mRNA and protein
expression were substantially higher in the 2 Gy group than in the control group. Conversely, the 4 Gy cell group
exhibited significantly decreased DNMT3b mRNA and protein expression relative to the control group. There were
substantially more TUNEL positive in the
125I seed implantation treatment group than in the control group, especially at
4 Gy. The 4 Gy seed implantation group showed weaker staining for DNMT1 and DNMT3b protein relative to the
control group. Consequently,
125I seed implantation inhibited cancer growth and reduced cancer volume.
Conclusion:
125I seed implantation kills pancreatic cancer cells, especially at 4 Gy.
125I-induced apoptosis and
changes in DNMT1 and DNMT3b expression suggest potential mechanisms underlying effective brachytherapy.
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Introduction
Pancreatic cancer is a devastating disease that is gener-
ally detected at a late stage. Surgical resection is the
only potentially curative treatment; however, only 10 to
20% of patients are candidates for curative surgical
resection due to advanced diagnosis, poor patient condi-
tion and tumor location. The remaining patients have to
seek alternative therapies [1-3]. Even with resection,
long term survival remains poor, with a median survival
of 12 - 20 months. The survival rate of pancreatic can-
c e rp a t i e n t si ss os h o r t ,t h a tt r e a t m e n tt e n d st ob ep a l -
liative. Recently, palliative surgery, endoscopic drainage,
chemotherapy or brachytherapy alone or in combination
have been used to elongate the survival and alleviate
pain or jaundice symptoms [4-7].
Iodine-125 (
125I) brachytherapy with either external
beam radiation therapy (EBRT) or interstitial bra-
chytherapy (IBT) improve local control and increase
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irradiation for efficacy [8]. Moreover, the very radiore-
sponsive organs surrounding the pancreas adversely
affect the dose of radiation used to target the tumor on
radiation treatment [9]. Fractionated EBRT is only effec-
tive on cancer cells before metastasis occurs, and the
efficiency of EBRT is usually impaired because, between
irradiation treatments, tumor cells in the stationary
phase enter the mitotic stage [8,9]. As a result, IBT has
been introduced as treatment for unresectable pancrea-
tic cancers to maximize local dose and minimize irradia-
tion of the surrounding normal tissue [10]. Recently,
125I
seed implantation, an efficient IBT technique, has
attracted increasing attention because of its specific
advantages: 1) effective irradiation dose applied in a sin-
gle procedure; 2) reduced irradiation outside the target
tumor; 3) elongating the tumor killing over several
weeks or months; 4) percutaneous implantation under
the guidance of ultrasound or CT [11,12].
Cancer irradiation therapy may keep tumor cells in
the sensitive resting period, resulting in tumor cell
apoptosis, inducing epigenetic changes to reactivate
silenced tumor suppressor genes, and damaging DNA to
kill the cancer cells. However, the radiobiological effect
of persistent and low-energy
125I irradiation, especially
on epigenetic modifications and apoptosis are not fully
understood. Cancer cell apoptosis is an indicator of
response to cancer treatment. Aberrant DNA methyla-
tion in cancer cells is a critical epigenetic process
involved in regulating gene expression. DNA hyper-
methylation is associated with tumor suppressor gene
silencing and defects in cell cycle regulation, resulting in
tumor development and progression [13,14]. The DNA
methyltransferases DNMT1, DNMT3a, and DNMT3b
are the three main functional enzymes that are responsi-
ble for establishing and maintaining DNA methylation
patterns in mammalian cells. The purpose of this study
is to investigate the effect of persistent and low-energy
125I seed irradiation on apoptosis and the expression
patterns of DNMTs in a mouse model of pancreatic
cancer.
Materials and methods
Cell lines and cell culture
Human SW-1990 pancreatic cancer cell lines obtained
from the American Type Culture Collection (Manassas,
VA) were maintained in DMEM (pH 7.4; Sigma, St.
Louis, MO) supplemented with 10% fetal bovine serum,
100 U/ml penicillin and 10 ng/ml streptomycin in a
humidified atmosphere of 95% air and 5% CO2 at 37°C.
In vitro
125I seed irradiation model
Model 6711
125Iw e r ek i n d l yp r o v i d e db yB e i j i n g
Research Institute of Medical Science Lin Chung.
A single seed is 0.84 mm in diameter, 4.5 mm long, has
a surface activity of 22.2 MBq, a half-life of 60.2 d,
and main transmission of 27.4 - 31.4 Kev X-ray and
35.5 Kev g-ray. Liquid paraffin was poured into a 6-cm
diameter cell culture dish. After the liquid solidified,
there was a 5-mm height distance between the surface
of the solid wax and the top of culture dish. In the par-
affin plaque, eight
125I seeds were evenly embedded
within recesses (4.5 mm × 0.8 mm) around a 35 mm
diameter circumference, with one
125I seed placed in the
center of the 60-mm dish (Figure 1A), in order to obtain
a relatively homogeneous dose distribution at the top of
the cell culture dish. A 35-mm culture dish was placed
on the in-house
125I irradiation model during the
experiment (Figure 1B). The culture dish was kept in
the incubator to maintain constant cell culture condi-
tions. The model was validated with thermoluminescent
dosimetry measurement using an empirical formula
from the American Association of Physicists in Medi-
cine (AAPM; 15). The absorbed dose for different expo-
sure time in various planes was also measured and
verified. The exposure time for delivering doses of 2 Gy
and 4 Gy are 44 and 92 h, respectively.
125 I irradiation and Cell Group
The adherent SW-1990 cells were detached by 0.25%
trypsin-EDTA until cells became a single cell suspension
when observed under the microscope. The digestion was
terminated by adding DMEM containing 10% fetal calf
serum. The single cell suspension was diluted to a con-
centration of 1 × 10
5 cells/ml and was transferred to
culture dishes with DMEM. Exponentially-growing
SW1990 cells in a cell culture dish were irradiated using
the in-house
125I seed irradiation model. The cell cul-
ture dishes were placed on the top of the in vitro
125I
seed irradiation model and placed in the incubator. The
culture dishes were rotated clockwise at specific time
intervals to guarantee even irradiation of the cells. The
cultured cells were randomly divided into three groups:
control group (0 Gy, without the embedded seed in the
paraffin), 2 Gy, and 4 Gy.
Apoptosis analysis by flow cytometry
Adherent SW 1990 cells cells were trypsinized and cen-
trifuged for 5 min at 220xg. Cells were then washed
three times in ice cold PBS and suspended in binding
buffer (0.01 M Hepes, pH 7.4; 0.14 M NaCl; 2.5 mM
CaCl2)a t1×1 0
6 cells/ml. The cells were stained with
annexin V-FITC (1 μl/ml) and propidium iodide (5 μg/
ml) for 15 min in the dark as described previously [15].
Cells were analyzed by fluorescence-activated cell sort-
ing (FACS) using a Coulter EPICS and MOdFit SOFT-
WARE (Verity Software House, Topsham, MN). Each
test was performed 3 times.
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Total RNA was retracted from SW 1990 cells using Tri-
zol reagent (Invitrogen, Carlsbad, CA). The housekeep-
ing gene glyceraldehyde-3-phosphate dehydrogenase
GAPDH was used as an internal reference [16]. Real-
time PCR was performed by using the following pri-
mers: for DNMT1, upstream primer 5’-GTGGGG
GACTGTGTCTCTGT-3’ downstream primer 5’-TGAA
AGCTGCATGTCCTCAC-3’, and amplified fragment
length of 204 bp; for DNMT3a, upstream primer
5’-ATCTCGCGATTTCTCGACTC- 3’, downstream pri-
mer 5’-GCTGAACTTGGCTATCCTGC -3’, and ampli-
fied fragment length of 180 bp; for DNMT3b, upstream
primer 5’-TTGAATATGAAGCCCCCAAG- 3’,d o w n -
stream primer 5’-TGATATTCCCCTCGTGCTTC -3’,
a m p l i f i e df r a g m e n tl e n g t ho f1 6 0b p ;f o rG A P D H ,
upstream primer 5’-GCACCGTCAAGGCTGAGAAC-3’,
downstream primer 5’-ATGGTGGTGAAGACGC-
CAGT-3’, amplified fragment length of 142 bp. Cycling
parameters: pre-denaturation 1 min, 95°C; denaturation
15 s, 95°C; annealing 15 s, 60°C; extension 45 s, 72°C,
40 cycles; final extension 5 min, 70°C. The PCR was
repeated three times for each sample. The standard
curve was generated with the ABI 7500 Real Time PCR
system (Applied Biosystems, Carlsbad, CA, USA) to
describe the linear relationship between threshold cycle
(Ct) value and relative quantity (RQ). RQ values were
obtained from measured Ct value with the following for-
mula: 2
(-ΔΔCt),w h e r eΔΔCt = ΔCtT; ΔCtS =( ΔCtT -
ΔCtTE )-( ΔCtS - ΔCtSE), T is the target sample, S is
the SW-1990 cell sample, and E is the reference. The
RQ of mRNA in all groups were calculated relative to
the RQ value in control group 1.
Western blotting
Western blotting was performed as described previously
[17,18]. Nuclear protein was prepared from SW-1990 pan-
creatic cancer cells with a Nuclear Protein extraction kit
(Fermentas, Ontario, CA). The total protein concentration
was determined by the Bradford assay using the Coomas-
sie Protein Assay Reagent Kit (Pierce Biotechnology, Rock-
ford, IL). Prepared protein samples (20 μg each) were
boiled for 5 min and loaded onto a 12% SDS polyacryla-
mide gel. After separation by electrophoresis and electro-
blotting to nitrocellulose membranes, membranes were
blocked by with 5% nonfat dry milk in 0.05% Tween 20
Tris-buffered saline (TTBS) at 4°C for 2 h. Membranes
were incubated with rabbit anti-human anti-DNMT1 anti-
body (1:1000; Abcam, Cambridge, MA), DNMT3a (1:1000;
Epitomics, Burlingame, CA) and DNMT3b (1:1000; Ima-
genex, Port Coquitlam, BC) at room temperature over-
night. After three washes with TTBS, blots were incubated
with horseradish peroxidase (HRP)-conjugated goat anti-
rabbit IgG antibody (1:5000) for 2 h at room temperature.
The membranes were visualized with an enhanced chemi-
luminescence (ECL) detection system (Pierce) and images
acquired using a Fluores-max instrument (Alpha Innotech,
Santa Clara, CA). The gray scale value of the respective
bands was quantified using Quantity One imaging soft-
ware (Bio-Rad Laboratories, Hercules, CA).
Figure 1
125I seed irradiation model developed in-house. In a 60-mm cell culture dish, eight
125I seeds were embedded in the solidified
paraffin evenly around the circumference of a 35-mm diameter, and one
125I seed was placed at the center of dish. This arrangement produced
a homogeneous dose distribution at the top of the cell culture dish, so that a 35-mm cell culture dish containing SW-1990 cells could be placed
on it during the experiment.
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The animals used in this study received humane care in
compliance with the Guide to the Care and Use of
Experimental Animals formulated by the Medical Ethical
Committee on animal experiments of the Second Mili-
tary Medical University. T w e n t yf o u r4w e e ko l dn u d e
mice weighing 18 to 20 g were anesthetized by intraper-
itoneal injection of sodium pentobarbital (50 mg/kg). In
a mini-laparotomy, the recipient rat pancreas was
exposed and a small stab wound made in the pancreas
parenchyma with a knife blade. The SW1990 cell sus-
pension (1 × 10
5 cells/ml, 0.2 ml) was inoculated under
the parenchyma of the pancreatic tail. Any leakage of
the cell suspension into abdominal cavity was carefully
removed with 75% ethanol to avoid peritoneal metasta-
sis. Ten days later, the ultrasonic images demonstrated
the formation of in situ pancreatic cancer with a tumor
diameter of 1.52 ± 0.31 cm.
After the diagnosis of pancreatic cancer was estab-
lished by ultrasound images during laparotomy, the 18-
gauge needles were implanted into the visible mass at
the tail of pancreas, and spaced in a parallel array at
intervals of approximately 0.5 cm. After the needles
were implanted,
125I seeds were implanted using a
Mick-applicator with the spacing maintained at approxi-
mately 0.5 cm. The mice with pancreatic cancer were
randomly divided into three groups. Groups I, II, and III
underwent the implantation of 0 Gy, 2 Gy, and 4 Gy
125I seeds, respectively. The 2 Gy or 4Gy irradiation
were achieved through implantation of 1 or 2 seeds,
respectively, into the pancreatic tumor. The
125I seed
have a average activity of 0.5 - 0.8 mCi. No seed implan-
tation was performed in the 0 Gy irradiation group.
After
125I seed implantation, two mice in the 0 Gy
group died; however, no death was observed in the 2 Gy
and 4 Gy groups.
Measurement of tumor volume by ultrasonic images
Ultrasonic inspection was performed through using a
GF-UCT240-AL5 (Olympus Co Ltd, Tokyo, Japan)
endoscopic ultrasound (EUS) 0 and 28 d post-implanta-
tion with a probe frequency of 12 MHz. After anesthe-
tizing the animals by intraperitoneal injection of sodium
pentobarbital (50 mg/kg), the mouse abdomen was
soaked with sterile deionized water. The ultrasonic
images were acquired using the EUS probe with a water
bag and the direct contact method. The long (a) and
short (b) diameters were measured from the ultrasonic
images. The volume of tumor was calculated according
to the following formula: a × b
2/2.
TUNEL staining
TUNEL staining was described previously [19]. Forma-
lin-fixed tissues were dehydrated, embedded in paraffin,
and sectioned. Tissue sections were deparaffinized with
xylene and rehydrated with graded dilution of ethanol
and fixed by 4% paraformaldehyde. The tissue sections
were incubated in 0.1% Triton X-100 in 0.1% sodium
citrate (SSC) for 15 min and 0.3% H2O2 for 3 - 5 min.
The slides were washed three times in phosphate-buf-
fered saline (PBS) and incubated with 50 μlo fT U N E L
reaction mixture (TdT and fluorescein-labeled dUTP) in
a humid atmosphere for 60 min at 37°C. After three
washes in PBS, the sections were incubated for 30 min
with an antibody specific for fluorescein-conjugated
horseradish peroxidase. The TUNEL stain was visualized
with a DAB substrate system in which nuclei with DNA
fragmentation stained brown. Slides were mounted in
neutral gum medium and were observed with an IX71
light microscope (Olympus, Tokyo, Japan). A commer-
cial fluorometric TUNEL system (DeadEnd; Promega,
Madison, WI) was used for analysis of apoptosis. Tissue
sections were examined microscopically using a 40×
objective; apoptotic cells were counted in 200 fields.
Alternatively, lenses were dissected from Formalin-fixed
eyeballs and pictures were taken with an MZ FLIII
stereomicroscope (Leica Microsystems, Deerfield, IL)
with bright-field transmitted light. All pictures were pro-
cessed in ImageJ to measure the surface area and height
of each lens for comparison.
Immunohistochemical staining
Immunohistochemical analysis was conducted as
described previously [20]. Tissues were obtained from
pancreatic cancer approximately 5 mm distant from the
center of the implanted
125I seed. Formalin-fixed tissues
were dehydrated, embedded in paraffin, and sectioned.
Tissue sections were deparaffinized, rehydrated, and
incubated for 30 min in 0.3% hydrogen peroxide in
methanol and then for 10 min with 1% goat serum in
TBS. Then the sections were incubated with rabbit anti-
human anti-DNMT1 antibody (Abcam), DNMT3a (Epi-
t o m i c s )a n dD N M T 3 b( I m a g e n e x ;a l la t1 : 1 0 0 )a tr o o m
temperature overnight. After washing three times in
TBS, the sections were incubated with biotinylated
mouse anti-rabbit IgG (1:5000; Abcam) for 30 min and
followed by three 5 min wash in TBS. The final incuba-
tion was for 30 min with HRP-avidin D at 37°C. The
peroxidase was detected with 0.05% 3,3-diaminobenzi-
dine tetrahydrochloride (DAB). The sections were coun-
terstained with hematoxylin and mounted in neutral
gum medium for light microscopy [21]. Positive protein
expression was visualized as nuclear localization of gran-
ular brown-yellow precipitate. The counts were per-
formed in 3 high power fields of vision under a high
magnification (400×) for each section. The percentage of
positive cells was calculated as the ratio of positive cells
to the total number of cells. The scoring scale for the
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24%; 2, 25 - 50%; 3, 51 - 75%; 4, more than 75%. The
scoring scale for staining intensity was: 0, no color; 1,
bright yellow; 2, yellow; 3, brown yellow; 4, brown. The
final score was obtained by multiplying the percentage
of positive cells by the staining intensity score.
Statistical analysis
All data were plotted as mean ± standard deviation. Sta-
tistical analysis was performed with SPSS 13.0 software.
(SPSS Inc., Chicago, IL). Student’stt e s tw a su s e df o r
comparisons. Differences were considered significant
when the P was less than 0.05.
Results
The continuous and low-energy
125I seed irradiation-
induced cell apoptosis
The red region in the lower left quadrant and right quad-
rant represented the survival and apoptosis of cells,
respectively. The red region area in lower quadrant in
2G yg r o u pw a ss l i g h t l yb i g g e rt h a nt h a ti n0G yg r o u p
(Figure 2A and 2B). The percentage of apoptotic cells
(3.15 ± 0.38%) in 2 Gy group was slightly more than that
in 0Gy group (1.78 ± 1.01%) (P < 0.05) (Figure 2D). More
importantly, the 4 Gy group exhibited a significantly
expanded red area relative to the 2Gy and 0 Gy group
(Figure 2A, B and 2C). The percentage of apoptotic cells
Figure 2 Apoptosis of
125I irradiated SW-1990 cells. The red region in the lower left quadrant represents apoptosis detected by flow
cytometry in the 0 Gy (A), 2 Gy (B), and 4 Gy (C) groups. The quantitation is shown in D. *P < 0.05 compared with the 0 Gy (Control) group.
#P < 0.05 compared with the 2 Gy group.
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in 2 Gy or 0 groups. (P < 0.01) (Figure 2D). Quantitative
measurements of apoptotic cell suggested that apoptosis
is an important mechanism of low-energy
125I seed irra-
diation inhibition of SW-1990 cancer cells.
Expression changes of DNMTs in SW-1990 cells after
125I
seed irradiation
Expression of DNMT1 (2.91 ± 0.5) and DNMT3b (2.31
± 0.54) mRNA in the 2 Gy group was significantly
higher than in the 0 Gy group (1.29 ± 0.33 and 1.56 ±
0.36, P < 0.05; Figure 3A and 3B). Conversely, the 4 Gy
group exhibited a significant decrease in DNMT1
expression (1.45 ± 0.70) and DNMT3b (0.90 ± 0.25)
mRNA compared with the 2 Gy group (P < 0.05; Figures
3A and 3B). More importantly, DNMT3b expression
was lower in the 4 Gy group (0.90 ± 0.25) than in the 0
Gy group (1.56 ± 0.36, P < 0.05; Figure 3B). Moreover,
DNMT3a mRNA expression did not differ among the
t h r e eg r o u p s( F i g u r e3 C ) .T h e s ed a t as u g g e s tt h a t
125I
seed irradiation significantly affects the expression of
DNMT1 and DNMT3a mRNA.
Representative western blots for DNMTs are shown in
the upper panel of Figure 4. The ratios of DNMTs to
GAPDH density were calculated to determine protein
expression levels. DNMT1 (1.65 ± 0.11) and DNMT3b
(12.65 ± 0.94) protein expression were dramatically
higher in the 2 Gy group than in the 0 Gy group (0.93
±0 . 0 7v s .8 . 0 4±0 . 3 9 ,P < 0.05; Figures 4A and 4B).
DNMT1 (0.93 ± 0.04) and DNMT3b (7.32 ± 0.85) pro-
tein expression decreased further in the 4 Gy group
compared with the 2 Gy group (P < 0.01; Figures 4A
and 4B). More importantly, the 4 Gy group (7.32 ±
0.85) exhibited decreased DNMT3b protein expression
relative to the 0 Gy group (8.04 ± 0.39, P <0 . 0 5 ;F i g u r e
4B). However, there were no significantly statistical dif-
ferences in DNMT3a protein expression among the
t h r e eg r o u p s .T h e s ed a t as u g g e s tt h a t
125I irradiation
significantly affects DNMT1 and DNMT3b protein
expression.
The number of apoptotic cells in pancreatic cancer after
125I seed implantation
The TUNEL-positive apoptotic cells were dark brown or
brownish yellow in color. Representative TUNEL stains
obtained from the 0 Gy, 2 Gy and 4 Gy groups are
showed in Figures 5A, B, and 5C, respectively. The aver-
age number of apoptotic cells increased slightly in the
2G yg r o u p( 2 . 0 7±0 . 5 7 )c o m p a r e dt ot h e0G yg r o u p
(1.83 ± 0.48, P < 0.05; Figure 5D). The average number
of apoptotic cells in the 4Gy group (7.04 ± 0.34) was
significantly higher than in the 2 Gy or 0 Gy group (P <
0.01; Figure 5D). These data suggest that the
125Is e e d
implantation induced significant apoptosis in pancreatic
cancer cells.
Immunohistochemistrical stains for DNMTs in pancreatic
cancer after
125I seed implantation
DNMT1, DNMT3b and DNMT3a protein expression
was detected as brownish yellow spots by immunohisto-
chemical staining (upper, middle and lower panel of
Figure 6, respectively). The brownish yellow staining for
DNMT1 and DNMT3a were more obvious in the 2 Gy
group than in the 0 Gy group. However, DNMT1 and
DNMT3b staining was significantly weaker in the 4 Gy
group compared with the 2 Gy group. More impor-
tantly, the brownish yellow for DNMT1 and DNMT3b
staining was moderately reduced in the 4 Gy group
compared with the 0 Gy group. There were no signifi-
cant differences in DNMT3a staining observed among
the three groups. These data suggest that
125Is e e d
implantation prominently altered the expression of
DNMT1 and DNMT3b, but not DNMT3a, in pancreatic
cancer.
Figure 3
125I irradiation induced expression changes of DNA methyltransferases mRNA in SW-1990 cells. DNMT1 (A), DNMT3a (B), and
DNMT3b (C) mRNA expression in
125I irradiated SW-1990 cells was detected as described in the Materials and Methods section. *P < 0.05
compared with the 0 Gy (Control) group.
#P < 0.05 compared with the 2 Gy group.
ΔP > 0.05 compared with the 0 Gy group.
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positive expression 28 d after
125I seed implantation.
DNMT1 (9.11 ± 3.64) and DNMT3b (7.27 ± 3.76) pro-
tein expression scoring in the 2 Gy group were dramati-
cally higher than in the 0 Gy group (6.72 ± 2.63 and
6.72 ± 2.63, P < 0.05). However, in the 4 Gy group,
there was a significant decrease in DNMT1 (6.50 ±
2.85) and DNMT3b (4.66 ± 2.17) protein expression
compared with 2 Gy group (P < 0.01). More impor-
tantly, the 4 Gy group (3.11 ± 2.42) exhibited a statisti-
cally decreased expression scoring of DNMT3b protein
relative to the 0 Gy group (4.72 ± 2.16, P < 0.05). More-
over, no significantly statistical differences were
observed in DNMT3a protein expression among the
three groups. Therefore, the expression changes in
DNMTs protein in an animal model was in agreement
with those observed in cultured cells subjected to simi-
lar
125I irradiation.
Histopathology of in pancreatic cancer after
125I seed
implantation
Representative HE sections were obtained from the 0 Gy
(Figure 7A), 2 Gy (Figure 7B), and 4 Gy (Figure 7C)
groups 28 d after
125I seed implantation. In the 0 Gy
group, there was no significant necrotic or damaged
regions. The cancer cells were densely arranged in a dis-
orderly fashion, with large, darkly stained nuclei with
obvious fission. In the 2 Gy and 4 Gy groups, a large
area of coagulative necrosis was observed around the
125I seed; also the surviving cells adjacent to the necrotic
region were loosely arranged, with nuclear condensation
and decreased eosinophilia of the cytoplasm. The cancer
cells in the submucosal layer were tightly packed with
nuclear condensation of discrete cells. More impor-
tantly, the necrosis and growth inhibition in cancer cells
were more obvious in 4Gy group than in 2 Gy group.
These suggestion that
125I seed implantation caused the
necrosis and growth inhibition of cancer cells and enlar-
gement of irradiation dose could enhance the beneficial
effect.
Tumor volume of pancreatic cancer at 0 and 28 days
after
125I seed implantation
Representative ultrasonic images from 0 and 28 d after
implantation of
125I seed in the 0 Gy, 2 Gy, and 4 Gy
groups are shown in Figure 8. Quantitative measure-
ments of tumor volume in the 0 Gy, 2 Gy, and 4 Gy
groups are shown in Figure 8C, F, and 8I, respectively.
In the 0 Gy group, pancreatic cancer proliferated rapidly
from 0 d to 28 d after implantation (Figures 8A and
8B). The tumor volume (1240 ± 351 v/mm
3)a t2 8d
was significantly larger than at 0 d (809 ± 261, P < 0.01;
Figure 8C). No significant alteration in tumor volume
was observed between 0 d and 28 d in the 2 Gy group
Figure 4
125I irradiation altered DNMTs protein expression in SW-1990 cells. Representative western blots of DNMT proteins are showed in
the upper panel. DNMT1 (A), DNMT3a (B), and DNMT3b (C) protein expression in
125I irradiated SW-1990 cells was detected as described in the
Materials and Methods section. *P < 0.05 compared with the 0 Gy (Control) group.
#P < 0.05 compared with the 2 Gy group.
ΔP > 0.05
compared with the 0 Gy group.
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in the tumor volume between 0 d and 28 d in the 2 Gy
group (750 ± 300 vs. 830 ± 221, P > 0.05; Figure 8F).
More importantly, the 4 Gy group demonstrated
that the treatment effectively eliminated the tumor
(Figures 8D and 8E). The tumor volume decreased dra-
matically, from 845 ± 332 at 0 d to 569 ± 121 at 28 d
(P < 0.01; Figure 8I). These results suggest that
125I seed
implantation inhibits tumor growth and reduces tumor
volume, with 4 Gy being more effective than 2 Gy.
Discussion
Epigenetic changes in cells are closely linked to tumor
occurrence, progression and metastases. DNA methylation
is a crucially important epigenetic alteration by which the
tumor suppressor gene expression and cell cycle regula-
tion may be substantially altered. Three different DNMTs,
specifically DNMT1, DNMT3a and DNMT3b, have criti-
cal roles in establishing and maintaining DNA methyla-
tion. Many chemotherapeutic agents exert their antitumor
effects by inducing apoptosis in cancer cells. The purpose
of this study is to investigate whether
125I seed irradiation
significantly influences the expression of DNA methyl-
transferases, promote the cell apoptosis and inhibit the
pancreatic cancer growth.
SW-1990 pancreatic cancer cells were cultured ex vivo
and implanted into the pancreas to create the animal
model. The
125I seed irradiation induced apoptosis in
Figure 5
125I irradiation induced apoptosis in pancreatic cancer. The dark brown or brownish yellow spots represented the apoptotic cells
detected by TUNEL staining in the 0 Gy (A), 2 Gy (B), and 4 Gy (C) groups. The average number of apoptotic cells per 200 objective fields were
plotted (D). *P < 0.05 compared with the 0 Gy (Control) group.
#P < 0.05 compared with the 2 Gy group.
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cells were present in pancreatic cancer receiving
125I
seeds implantation. Irradiation-induced apoptosis
became more obvious when the radiation dose increased
from 2 Gy to 4 Gy. DNMT1 and DNMT3b mRNA and
protein expression was increased substantially in 2 Gy
125I irradiated SW-1990 cells, whereas
125Ii r r a d i a t i o n
with 4 Gy inhibited DNMT3b mRNA and protein
expression. The expression of DNMT3a mRNA did not
Figure 6 Immunohistochemical staining for DNMTs in
125I seed implanted pancreatic cancer. Representative staining sections for DNMT1
(upper), DNMT3b (middle) and DNMT3a (lower) were prepared as described in the Materials and Methods section. The brownish yellow spots
represent positive staining. Scale bars represent 500 μm.
Table 1 The positive expression scoring of DNMTs
protein in
125I pancreatic cancers
DNMT1 DNMT3b DNMT3a
Control Group (0Gy) 6.72 ± 2.63 4.72 ± 2.16 2.61 ± 1.24
2Gy Group 9.11 ± 3.64* 7.27 ± 3.76* 3.22 ± 1.30
Δ
4Gy Group 6.50 ± 2.85
#Δ 3.11 ± 2.42*
# 3.06 ± 2.13
Δ
DNMT, DNA methyltransferases.
*P < 0.05 compared with 0 Gy (Control) group.
#P < 0.05 compared with 2 Gy
group.
ΔP > 0.05 compared with 0 Gy group.
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Page 9 of 12Figure 7 Pathology of
125I implanted pancreatic cancer. Representative HE stained sections from the 0 Gy (A), 2 Gy (B), and 4 Gy (C) groups
28 d after
125I seed implantation were prepared as described in the Materials and Methods section.
Figure 8 Tumor volume 0 and 28 d after
125I seed implantation. The upper, middle, and lower panels show representative ultrasound
images from 0 Gy (upper), 2 Gy (middle), and 4 Gy (lower) groups 0 and 28 d post
125I seed implantation. *P < 0.05 compared with 0 d post-
implantation;
ΔP > 0.05 compared with 0 d post-implantation.
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Page 10 of 12change regardless of the
125I irradiation dose. The simi-
lar DNMT expression patterns were confirmed by
immunohistochemical staining in
125Is e e di m p l a n t e d
pancreatic cancer. Most importantly, the 2 Gy
125Is e e d
implantation limited the growth of the pancreatic
tumor, while 4 Gy
125I seed implantation substantially
decreased pancreatic tumor volume.
Our results demonstrated that apoptosis may have an
important role in the therapeutic effects when pancreatic
cancer is exposed to continuous low-energy
125I irradia-
tion. The apoptosis in the 4 Gy group was more obvious
than in the 2 Gy group, which is in agreement with the
fact that cancer treatment is more effective at 4 Gy than at
2 Gy. Similar irradiation-induced apoptosis patterns were
also observed in the other cancer cell lines [22]. The
125I
irradiation induced apoptosis was the primary mechanism
of CL187 colonic cancer cell-killing under low dose treat-
ment [22]. Ionizing radiation can generate the reactive
oxygen species (ROS), which induce apoptosis [23]. The
ROS damages critical cellular components such as DNA,
proteins, and lipids, eventually causing cellular apoptosis
[24]. Therefore, the
125I irradiation-induced apoptosis is a
key mechanism underlying the therapeutic effect of
125I
seed implantation in pancreatic cancer.
Our results demonstrated that altered DNA methyla-
tion patterns might have a pivotal role in tumor inhibi-
tion resulting from consecutive low-energy irradiation.
The 2 Gy irradiation caused a significant increase in
DNMTs expression, whereas 4 Gy irradiation was asso-
ciated with decreased DNMTs expression. However, a
substantial reduction in tumor volume was only
observed in 4 Gy irradiation group rather than in 2 Gy
group at 28 d after
125I seed implantation. There are a
strong and positive correlation between DNA methyla-
tion and expression of DNMTs, because DNMTs main-
tain DNA methylation patterns [25]. Therefore, it is
reasonable to speculate that DNA hypomethylation sig-
nificantly inhibits cancer cell proliferation or impairs
cell survival potentially to an even greater extent than
DNA hypermethylation. X- and g-radiation induce DNA
hypomethylation paralleled by decreased DNMTs
expression in somatic cells [25-28]. Actually, low-dose
irradiation (2Gy) predominantly resulted in reversible
DNA damage, which was associated with DNA repair.
The DNMTs are the key enzyme for DNA repair. As a
result, the increase in reactive DNMTs expression
reflects active DNA repair. Thus,
125I irradiation-
induced DNA hypomethylation could be the key
mechanism by which
125I seed implantation lead to
tumor growth inhibition.
Aberrant de novo DNA methylation is commonly
associated with cancer, and DNA methylation in mam-
malian cells largely occurs on cytosine residues at CpG
dinucleotides in genomic DNA. The de novo methyla-
tion of CpG islands in promoter regions of tumor sup-
pressor genes can result in silencing [29]. Thus, DNA
hypermethylation might lead to cancer generation and
progression [29]. The irradiation-induced DNA
demethylation, as the result of decreased DNMTs
expression, can reactivate the tumor suppressor gene
and inhibit tumor growth. The inhibitory effect of DNA
demethylation on cancer was also demonstrated by the
demethylating agent 5-aza-cytidine (AZA) and zebular-
ine. Incorporation of a demethylating agent (like a cyti-
dine analog) into DNA during replication inhibited
DNMTs enzyme activity and demethylated the tumor
suppressor genes, eventually leading to tumor growth
inhibition [30,31]. AZA demethylates the P16 and
pMLHI gene promoters and reactivates these previously
silenced tumor suppressor genes [30,32]. Zebularine
administration depleted DNMT1 and the demethylation
of the P16 and RASSFIA gene promoters [33,34]. Acti-
vation of the tumor suppressor genes RASSF1A and P16
inhibited cell proliferation by inhibiting accumulation of
cyclin D, which arrests cell cycle progression at the G1/
S phase transition [35]. G1 includes a restriction point
beyond which the cell is committed to undergo division
independent of growth regulatory signals. As a result,
the mechanisms underlying the inhibitory effect of DNA
hypomethylation on tumors could be related to reacti-
vating tumor suppressor genes and negative regulation
of cell cycle progression.
In conclusion, our study provides important insight
into the mechanism by which
125I seed irradiation
affects pancreatic cancer.
125I seed implantation effec-
tively inhibited tumor growth and reduced tumor
volume, especially at 4 Gy.
125Ii r r a d i a t i o n - i n d u c e d
apoptosis and DNA hypomethylation are two key
mechanisms underlying the therapeutic effect of low-
energy
125I seed implantation.
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